PFM Health Sciences’s Henry Schein HSIC Stock Holding History
Bought
Maintained
Sold
Other funds holding HSIC
KKRC
PFM Health Sciences's HSIC Position: Q2 2026 in Review
PFM Health Sciences reduced its Henry Schein (HSIC) stake by 12% in Q2 2026, selling an estimated $1.43M and leaving 134,423 shares worth $11.2M. The position accounts for 0.96% of the portfolio, ranked #40.
PFM Health Sciences first reported a position in HSIC in Q3 2020 and has held it in 4 quarters since. The position peaked at $26.4M in Q4 2020. 562 funds tracked by Wall St. Rank hold HSIC as of Q2 2026.
- PFM Health Sciences held 134,423 shares of Henry Schein worth $11.2M as of Q2 2026.
- PFM Health Sciences sold 18,691 Henry Schein shares in Q2 2026, an estimated $1.43M.
- Henry Schein made up 0.96% of PFM Health Sciences's portfolio in Q2 2026, its #40 holding.
- PFM Health Sciences first reported a position in Henry Schein in Q3 2020 and has held it in 4 quarters since.
- PFM Health Sciences's Henry Schein position peaked at $26.4M in Q4 2020.
- 562 funds tracked by Wall St. Rank held Henry Schein as of Q2 2026.
Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.